Bronchiectasis is a clinical condition defined as a chronic, abnormal dilation of the bronchi accompanied by classical ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

The Committee for Medicinal Products for Human Use adopted a positive opinion for NVS' Kisqali to help reduce the risk of recurrence in people with HR+/HER2- early breast cancer.

Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance taking a minority 2% position.

Terns Pharmaceuticals' (TERN) stock has risen somewhat due to some optimism around its early-stage clinical programs ...

Global Clostridium Difficile Infections Treatment MarketThe global Clostridium Difficile Infections (CDI) treatment market is ...

Necrobiosis Lipoidica Diabeticorum MarketThe global Necrobiosis Lipoidica Diabeticorum (NLD) market is expected to be worth USD 4.5 billion in 2023 and USD 8.06 billion by 2033, with a CAGR of 6% from ...

Please note Chef Michelle Bernstein is a COSENTYX® (secukinumab) patient and has been compensated for her time. Continue reading for Important Safety Information and a link to the full Prescribing ...

The Froedtert & MCW health network has been using the Xealth digital health platform, which is integrated into its EHR system ...

In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the benefits of rabbit monoclonal antibodies in ...

The Global Non-Small Cell Lung Carcinoma (NSCLC) Market is on the brink of an extraordinary transformation, with market ...

The remarkable surge in the Intratumoral Cancer Therapies market is primarily attributed to the favorable regulatory ...